Patents Assigned to Lycored Bio Ltd.
  • Extended release compositions comprising as active compound venlafaxine hydrochloride
    Patent number: 8557282
    Abstract: The present invention relates to an extended release composition comprising as active compound Venlafaxine Hydrochloride, in which Venlafaxine Hydrochloride is coated on a non pareil inert core, which coated core is then coated with polymeric layer which enables the controlled release of the Venlafaxine Hydrochloride.
    Type: Grant
    Filed: November 21, 2011
    Date of Patent: October 15, 2013
    Assignee: Lycored Bio Ltd.
    Inventor: Yoram Sela
  • EXTENDED RELEASE COMPOSITIONS COMPRISING AS ACTIVE COMPOUND VENLAFAXINE HYDROCHLORIDE
    Publication number: 20130115298
    Abstract: The present invention relates to an extended release composition comprising as active compound Venlafaxine Hydrochloride, in which Venlafaxine Hydrochloride is coated on a non pareil inert core, which coated core is then coated with polymeric layer which enables the controlled release of the Venlafaxine Hydrochloride.
    Type: Application
    Filed: November 21, 2011
    Publication date: May 9, 2013
    Applicant: LYCORED BIO LTD.
    Inventor: Yoram SELA
  • EXTENDED RELEASE COMPOSITIONS COMPRISING AS ACTIVE COMPOUND VENLAFAXINE HYDROCHLORIDE
    Publication number: 20120135082
    Abstract: The present invention relates to an extended release composition comprising as active compound Venlafaxine Hydrochloride, in which Venlafaxine Hydrochloride is coated on a non pareil inert core, which coated core is then coated with polymeric layer which enables the controlled release of the Venlafaxine Hydrochloride.
    Type: Application
    Filed: November 21, 2011
    Publication date: May 31, 2012
    Applicant: LYCORED BIO LTD.
    Inventor: YORAM SELA
  • Extended release compositions comprising as active compound venlafaxine hydrochloride
    Patent number: 8062666
    Abstract: The present invention relates to an extended release composition comprising as active compound Venlafaxine Hydrochloride, in which Venlafaxine Hydrochloride is coated on a non pareil inert core, which coated core is then coated with polymeric layer which enables the controlled release of the Venlafaxine Hydrochloride.
    Type: Grant
    Filed: November 7, 2002
    Date of Patent: November 22, 2011
    Assignee: Lycored Bio Ltd.
    Inventor: Yoram Sela
  • FORMULATIONS FOR POORLY SOLUBLE DRUGS
    Publication number: 20100291200
    Abstract: The present invention provides a drug delivery system comprising nanoparticles or microparticles of a water poorly soluble drug dispersed in a polymeric bead containing essentially only of hydrophilic polymers (i.e. without hydrophobic polymers). The present invention further provides a method of producing the drug delivery system of the invention.
    Type: Application
    Filed: July 27, 2010
    Publication date: November 18, 2010
    Applicant: LYCORED BIO LTD.
    Inventors: Shlomo MAGDASSI, Yoram SELA, Keren COHEN